Curcumin inhibits the proliferation and invasiveness of MHCC97-H cells via p38 signaling pathway

Drug Development Research

Volumn 75, Issue 7, 2014, Pages 463-468

  Zhang, Kai ^a   Rui, Xiaojiang ^a   Yan, Xi ^a  

^a The People s Liberation Army 323 Hospital   (China)

Author keywords

curcumin; hepatocellular carcinoma; migration and invasion; MMP

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CURCUMIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; ANTINEOPLASTIC AGENT; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LIVER CELL CARCINOMA; METASTASIS INHIBITION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; ZYMOGRAPHY; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; ENZYMOLOGY; LIVER TUMOR; METABOLISM; NEOPLASM INVASIVENESS; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CURCUMIN; DRUG SYNERGISM; HUMANS; IMIDAZOLES; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PYRIDINES;

EID: 84926315350     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21210     Document Type: Article

References (20)

1. Abdalla SA, Jeziorska M, Schofield P, Woolley DE, Haboubi NY,. 1997. Gelatinase B (MMP-9) expression and survival in colorectal cancer patients. Int J Colorectal Dis 12: 342-343.
2. Backus J, Laughlin T, Wang Y, Belly R, White R, Baden J, Justus Min C, Mannie A, Tafra L, Atkins D, et-al. 2005. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 7: 327-336.
3. Chen J, Wang G, Wang L, Kang J, Wang J,. 2010. Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells. Eur J Pharm Sci 41: 210-218.
4. Chen K, Zhang S, Ji Y, Li J, An P, Ren H, Liang R, Yang J, Li Z,. 2013. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. PLoS ONE 8: e72927.
5. Hsieh MJ, Chen KS, Chiou HL, Hsieh YS,. 2010. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Eur J Cell Biol 89: 598-606.
6. Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB,. 2009. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 125: 2187-2197.
7. Li ZC, Zhang LM, Wang HB, Ma JX, Sun JZ,. 2014. Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1. Tumour Biol 35: 111-116.
8. Lim TG, Lee SY, Huang Z, Lim do Y, Chen H, Jung SK, Bode AM, Lee KW, Dong Z,. 2014. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2. Cancer Prev Res (Phila) 7: 466-474.
9. Merdad A, Karim S, Schulten HJ, Dallol A, Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM, Al-Qahtani MH,. 2014. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis. Anticancer Res 34: 1355-1366.
10. Mimori K, Kataoka A, Yoshinaga K, Ohta M, Sagara Y, Yoshikawa Y, Ohno S, Barnard GF, Mori M,. 2005. Identification of molecular markers for metastasis-related genes in primary breast cancer cells. Clin Exp Metastasis 22: 59-67.
11. Mo N, Li ZQ, Li J, Cao YD,. 2012. Curcumin inhibits TGF-beta1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells. Asian Pac J Cancer Prev 13: 5709-5714.
12. Nasr M, Selima E, Hamed O, Kazem A,. 2014. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharmacol 723: 267-275.
13. Rao W, Li H, Song F, Zhang R, Yin Q, Wang Y, Xi Y, Ge H,. 2014. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells. Carcinogenesis 35: 1573-1581.
14. Veltri RW, Isharwal S, Miller MC, Epstein JI, Partin AW,. 2010. Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: a prospective evaluation with up to 25 years of follow-up after radical prostatectomy. Prostate 70: 1333-1339.
15. Villanueva A, Minguez B, Forner A, Reig M, Llovet JM,. 2010. Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. Annu Rev Med 61: 317-328.
16. Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, Lu N, Guo QL,. 2010. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett 297: 42-48.
17. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, Tridandapani S, Anant S, Kuppusamy P,. 2007. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6: 178-184.
18. Yang N, Hui L, Wang Y, Yang H, Jiang X,. 2014. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep 31: 2651-2659.
19. Yang ZH, Li SN, Liu JX, Guo QX, Sun XW,. 2012. MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population. Mol Biol Rep 39: 9399-9404.
20. Zhao FT, Jia ZS, Yang Q, Song L, Jiang XJ,. 2013. S100A14 promotes the growth and metastasis of hepatocellular carcinoma. Asian Pac J Cancer Prev 14: 3831-3836.